SecBot SecBot
8-K ·Filed Apr 6, 2026

ELAB

PMGC Holdings Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed6mo ago SEC0001213900-26-040150
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

This is a speculative, early-stage development with no immediate financial impact. Traders should monitor for future announcements regarding exercise of the option, definitive licensing, or financing activities. Given the company's small market cap ($7M) and lack of disclosed financial terms, any future funding or partnership could significantly influence stock volatility.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
ELAB ▼ -66.67% at T+60d
NEUTRAL call -66.67% · α vs SPY -80.14% · entry $3.84 → $1.28
Entry = T+0 close
Apr 6, 2026
via day close
T+1d
-10.16%
call -10.16% · α -10.22%
$3.45
settled 7mo ago
T+5d
+32.29%
call +32.29% · α +28.16%
$5.08
settled 7mo ago
T+20d
-39.32%
call -39.32% · α -48.31%
$2.33
settled 6mo ago
T+60d
-66.67%
call -66.67% · α -80.14%
$1.28
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

PMGC Holdings Inc. announced through its subsidiary NorthStrive Defense Tech that it has acquired an exclusive option to license a multi-domain drone technology capable of transporting payloads across air and water environments. The technology, covered under U.S. Patent No. 12,291,334, enables improved payload efficiency using buoyancy-assisted transport and is targeted at defense applications such as littoral logistics and sensor deployment.

Key Facts

  • NorthStrive Defense Tech LLC, a wholly-owned subsidiary of PMGC Holdings, entered into an exclusive option agreement for a drone technology with multi-domain (air and water) payload transport capabilities.
  • The technology is protected under U.S. Patent No. 12,291,334 and includes an option for an exclusive patent license and non-exclusive know-how in the aerospace and defense field.
  • No financial terms of the option agreement were disclosed.
  • If exercised, the company will negotiate a definitive licensing agreement; however, there is no guarantee of successful negotiation or commercialization.
  • The company plans to develop a commercialization strategy and secure financing during the option period.

Financial Impact

Undisclosed — no financial terms, deal value, or funding commitments were revealed.

dilutiondebtrevenueeps

Risk Factors

  • No assurance that a definitive license agreement will be reached.
  • Technology may not be successfully developed or commercialized.
  • Company provides no revenue or earnings visibility from this initiative.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-040150
Document: ea028516101ex99-1.htm0001213900-26-040150
Document: 0001213900-26-040150-index-headers.html0001213900-26-040150
Document: 0001213900-26-040150-index.html0001213900-26-040150
Document: 0001213900-26-040150.txt0001213900-26-040150
27 reports for ELAB
Performance horizon
33% Hit rate @ T+1 2 of 6 directional calls Went positive at some point 2 of 6 best @ T+60▲ +66.87%Apr 20, 2026
Filters
Rows
Reports for ELAB — sortable, filterable
TypeNow
Sep 29, 2026
28d ago
Press Release
NEUTRAL ★ 3/10
$3.67 $3.54▼ −3.54%▼ −3.34%$2.61 (−28.88%)
Sep 18, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$4.78 $4.42▼ −7.53%▼ −9.08%$2.61 (−45.40%)
Sep 18, 2026
5w ago
Press Release
NEUTRAL ★ 4/10
$4.78 $4.42▼ −7.53%▼ −9.08%$2.61 (−45.40%)
Aug 19, 2026
9w ago
Press Release
NEUTRAL ★ 3/10
$0.5603 $0.6100▲ +8.87%▲ +9.71%$2.61 (+365.82%)
Aug 14, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$0.9100 $0.8730▼ −4.07%▼ −3.59%$2.61 (+186.81%)
Jul 29, 2026
12w ago
Press Release
NEUTRAL ★ 3/10
$0.8800 $0.9493▲ +7.88%▲ +6.20%$2.61 (+196.59%)
Jul 9, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$1.12 $1.09▼ −2.68%▼ −1.91%$2.61 (+133.04%)
Jul 1, 2026
16w ago
8-K
BULLISH ★ 5/10
$1.28 $1.18▼ −7.81%▼ −7.68%$2.61 (+103.91%)
Jun 8, 2026
20w ago
Press Release
NEUTRAL ★ 4/10
$1.59 $1.41▼ −11.32%▼ −11.03%$2.61 (+64.15%)
Jun 5, 2026
20w ago
8-K
NEUTRAL ★ 4/10
$1.59 $1.41▼ −11.32%▼ −11.03%$2.61 (+64.15%)
Showing 10 of 27

US Market Status

Market Closed — Opens in 1h

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 6, 2026